Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- NAITREIndependent statistical analysis of Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nalrexone Facilitated Discontinuation of Buprenorphine: Complete Statistical AnalysisIndependent statistical analysis of Nalrexone Facilitated Discontinuation of Buprenorphine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01895036).
- Naltrexone for Impulse Control Disorders in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Naltrexone for Impulse Control Disorders in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01052831).
- NAPIndependent statistical analysis of Neural-net Artificial Pancreas (NAP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05876273).
- NAPEIndependent statistical analysis of Oatmeal Effect on N-acyl-phosphatidylethanolamines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03468179).
- Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: Complete Statistical AnalysisIndependent statistical analysis of Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03167541).
- NAPSIndependent statistical analysis of Nattokinase Atherothrombotic Prevention Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080520).
- NARLALIndependent statistical analysis of Navelbine And Radiotherapy in Locally Advanced Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00887783).
- Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: Complete Statistical AnalysisIndependent statistical analysis of Nasal HFOV Versus Nasal CPAP to Reduce Post-extubation pCO2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02340299).
- NASHIndependent statistical analysis of Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NASHIndependent statistical analysis of The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASH Fitness Intervention in Thrombosis Trial (NASHFit): Complete Statistical AnalysisIndependent statistical analysis of NASH Fitness Intervention in Thrombosis Trial (NASHFit): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03518294).
- NASH-CXIndependent statistical analysis of Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis: primary endpoint results,…
- Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: Complete Statistical AnalysisIndependent statistical analysis of Nasotracheal Suction With Tiemann Catheter Compared to the Classic Technique With the Suction Catheter: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NASQIndependent statistical analysis of Individualized Nutrition for Adult Recipients of Allogeneic Stem Cell Transplants - Effect on Quality of Life: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Natalizumab High Titer Immunogenicity and Safety: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab High Titer Immunogenicity and Safety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00516893).
- Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: Complete Statistical AnalysisIndependent statistical analysis of Natalizumab in the Treatment of Rheumatoid Arthritis in Subjects Receiving Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: Complete Statistical AnalysisIndependent statistical analysis of National Comprehensive Cancer Network (NCCN) Decision Support Tool for Patients With NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics: Complete Statistical AnalysisIndependent statistical analysis of National Survey to Understand Ethical, Legal and Social Issues in Communicating to the Public About Epigenetics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Natreon Healthy Skin Study – PrimaVie Supplement: Complete Statistical AnalysisIndependent statistical analysis of Natreon Healthy Skin Study - PrimaVie Supplement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02762032).
- Natural Killer (NK) Cell Transplantation for AML: Complete Statistical AnalysisIndependent statistical analysis of Natural Killer (NK) Cell Transplantation for AML: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00187096).
- NAUSICAIndependent statistical analysis of Novel Angioplasty Using Coronary Accessor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00815997).
- NAV4-04Independent statistical analysis of Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I – II Trial: Complete Statistical AnalysisIndependent statistical analysis of Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- NAVIGATE-ADIndependent statistical analysis of A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- NavigatorIndependent statistical analysis of A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3…
- Navigator II Continuous Glucose Monitor Home Use Study: Complete Statistical AnalysisIndependent statistical analysis of Navigator II Continuous Glucose Monitor Home Use Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01455064).
- NAVIOIndependent statistical analysis of A Retrospective Study of the Navio Robotic-assisted Surgical System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03072459).
- NC_NEXUSIndependent statistical analysis of North Carolina Newborn Exome Sequencing for Universal Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02826694).
- NCT01009034Independent statistical analysis of Concentrations of Maraviroc in the Semen of HIV-Infected Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01009034).
- NDV-HXP-S Vaccine Clinical Trial (COVIVAC): Complete Statistical AnalysisIndependent statistical analysis of NDV-HXP-S Vaccine Clinical Trial (COVIVAC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05940194).
- Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00566709).
- Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Near Infrared Spectroscopy Cortical Response to Noxious and Auditory Stimuli in Subjects Under General Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- NEAR-2Independent statistical analysis of An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- nebhctzIndependent statistical analysis of Treatment of OSA Associated Hypertension With Nebivolol or Hydrochlorothiazide: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02710071).
- Nebulized Hypertonic Saline for Inpatient Use in COPD: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Inpatient Use in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02266875).
- Nebulized Hypertonic Saline for Mechanically Ventilated Children: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Hypertonic Saline for Mechanically Ventilated Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01945944).
- Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Magnesium Sulfate in Children With Moderate to Severe Asthma Exacerbation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Nebulized Sub-dissociative Dose Ketamine for Treating Pain: Complete Statistical AnalysisIndependent statistical analysis of Nebulized Sub-dissociative Dose Ketamine for Treating Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03909607).
- Needle Guidance in Ultrasound Guided Nerve Blocks: Complete Statistical AnalysisIndependent statistical analysis of Needle Guidance in Ultrasound Guided Nerve Blocks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02080481).
- Neem Lotion With Combing for Lice: Complete Statistical AnalysisIndependent statistical analysis of Neem Lotion With Combing for Lice: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02974088).
- NefigardIndependent statistical analysis of Efficacy and Safety of Nefecon in Patients With Primary IgA (Immunoglobulin A) Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neo ALTTOIndependent statistical analysis of Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00553358).
- Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: Complete Statistical AnalysisIndependent statistical analysis of Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04512430).
- Neo-Synalar Modified 48 Hour Patch Test: Complete Statistical AnalysisIndependent statistical analysis of Neo-Synalar Modified 48 Hour Patch Test: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02168478).
- Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01263769).
- Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: Complete Statistical AnalysisIndependent statistical analysis of Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…